Approved Study Database

Ref. No. Scientific Title Principal investigator
2002.338 A Study on the Viral Kinetics of Different Regimes of Pegylated Interferon and Lamivudine Combination Theerpy in HBeAg Positive Chronic Hepatitis B (Revised : cre-2002.203-t) Prof. Chan Lik Yuen Henry
2005.028 A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B Prof. Chan Lik Yuen Henry
2005.428 Intrahepatic Assessment of Hepatitis B Virus in Hepatocellular Carcinoma CHAN Lik Yuen Henry
2011.284 A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with peg-IFN Prof. Chan Lik Yuen Henry
2005.279 An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Indenix-Sponsored Telbivudine Studies Prof. Chan Lik Yuen Henry
2007.203 Virological Monitoring of Anti-Viral Treatment in Chronic Hepatitis B CHAN lik Yuen Henry
2003.148 A Multinational Phase 2 Study of LY582563 in the Treatment of Patients with Chronic Hepatitis B Viral Infection Prof. Chan Lik Yuen Henry
2013.264 A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients Prof. Chan Lik Yuen Henry
2007.206 A Comparative Study of Entecavir vs Adefovir plus Lamivudine vs Combination Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study Prof. Chan Lik Yuen Henry
2006.297 Surveillance for Early Liver Cirrhosis in Chronic Hepatitis B Patients in Hong Kong Using Transient Elastography CHAN Lik Yuen Henry
2004.332 Double-blinded, Randomized Trial of Thymosin-alfa-1 and Peginterferon alfa-2a (40 KD) (PEGASYS_) Combination Therapy versus Peginterferon Alfa-2a (40 KD) (PEGASYS_) Monotherapy in the Treatment of Chronic Hepatitis B Prof. Chan Lik Yuen Henry
2004.303 Combination Treatment of Peginterferon alfa-2b (PegIntron Prof. Chan Lik Yuen Henry
2004.304 A Randomized, Open Label Trial of Telbivudine (LdT) versus Adefovir Dipivoxil in Adults with HBeAg-Positive, Compensated Chronic Hepatitis B Prof. Chan Lik Yuen Henry
2003.149 A Long-Term Observation Study of Safety, Efficacy, and Viral Resistance with LY582563: A Multinational Extension Study in Chronic Hepatitis B-Infected Patients Prof. Chan Lik Yuen Henry
2004.336 Role of Hepatitis B Virus Covalently Closed Circular DNA in Determination of Treatment Outcome CHAN Lik Yuen Henry
2009.487 Evaluation of 3' deleted HBx mutant as a serum marker to predict hepatocellular carcinoma in chronic hepatitus B CHAN Lik Yuen Henry
2009.242 Viral Genomic Determinatns of Liver Fibrosis in Chronic Hepatitis B CHAN Lik Yuen Henry
2004.344 Proteomic Profiling of Liver Fibrosis in Chronic Hepatitis B CHAN Lik Yuen Henry
2009.318 Health Related Quality of Life in Patients with Chronic Hepatitis C in Hong Kong CHAN Lik Yuen Henry
2009.438 Association of serum hepatitis B surface antigen level with the risk of hepatocellular carcinoma CHAN Lik Yuen Henry
2004.426 Interface of Diagnostic Method Between Chinese and Western Medicine in Chronic Hepatitis B CHAN Lik Yuen Henry
2010.144 The impact of drug resistance testing in the management of patients with chronic hepatitis B on antiviral therapy - A retrospective study and survey CHAN Lik Yuen Henry
2012.216 Risk of advanced colorectal neoplasm in patients with non-alcoholic fatty liver disease CHAN Lik Yuen Henry
2010.071 Presictive value of week 24 response for long-term outcomes of entecavir therapy in patients with chronic hepatitis B CHAN Lik Yuen Henry
2011.426 The use of serum interleukin-6 and interleukin-10 in prognostication of advanced hepatocellular carcinoma CHAN Lam Stephen
2010.356 A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib Dr. Chan Lam Stephen
2010.205 Prospective randomized double-blind placebo controlled trial to assess the role of lamivudine in patients with hepatitis B related-hepatocellular carcinoma not suitable for oncologic therapy due to poor liver function Prof. Chan Lam Stephen
2007.077 Noise Level Measurement at Public Hospitals in Hong Kong CHAN Lam Lam Anne
2006.131 Epigenetic Inactivation of Wnt Inhibitoary Factor 1 (WIF-1) in Hepatocellular Carcinoma CHAN Lam
2004.107 Reducing Blood Exposures and Sharps-Related Injuries in Operating Theatre CHAN Lai Sze Connie (No email contact)
2006.347 An Open-Label, Multicenter, Randomized Study of Combination Therapy with Oral Telbivudine Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-Positive Patients with Chronic Hepatitis B Who are Lamivudine Resistant Prof. Chan L.Y. Henry
2007.322 A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy versus the Combination of Emtricitabine and Tennofovir DF for the Treatment of Chronic Hepatitis B Prof. Chan L.Y. Henry
2004.061 Role of ERRs in the Development of Prostrate Cancer CHAN L Franky
2004.194 Blood Markers in Acute Appendicitis: Development of a Rapid Test for the Early Diagnosis of Acute Appendicitis CHAN Kwan Chee Allen
2005.105 Investigation of the Integrity of Circulating Cell-Free RNA in the Plasma of Pregnant Women CHAN Kwan Chee Allen
2005.013 Plasma EBV DNA Analysis in Patients with Renal Disease CHAN Kwan Chee Allen
2004.131 Serial Analysis of the Molecular Size of Plasma Epstein-Barr virus and Genomic DNA during Radiotherapy in Nasopharyngeal Carcinoma Patients CHAN Kwan Chee Allen
2006.146 Investigation of the Possible Detection of Methylated RASSF1A Sequence in the Plasma of Healthy Control Subjects and its Quantitative Relationship with Age CHAN Kwan Chee Allen
2005.233 Evaluation on Newer Serological Markers for Early Detection of Nasopharyngeal Carcinoma CHAN KS Paul
2009.014 Molecular basis of viral RNA polymerase complex as a restriction to host adaptation of influenza viruses CHAN KS Paul
2002.191 Study of the Natural History of Non-NSAID, Non-Hp Bleeding Peptic Ulcers (NNH Study) CHAN KL Francis
2003.108 Preventing NSAID-Associated Ulcer Bleeding for High-Risk Patients: From Cyclooxygenase-2 to Therapeutics (Study A. Effect of Inhibition of COX-2 on Prostaglandia Synthesis in Previously Damaged Gastric Mucosal Barrier CHAN KL Francis
2004.116 H. Pylori-negative Idiopathic Bleeding Ulcer: An Emerging Disease in the Post-H. Pylori era. CHAN KL Francis
2007.028 A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 8-Week Comparative Efficacy and Safety Study of Esomeprazole 20 mg qd Versus Ranitidine 150 mg bid in Patients with An NSAID-Associated Gastric Ulcer When Daily NSAID is Continued Prof. Chan KL Francis
2004.368 Amendment #3 for Clinical Protocol for Prof. Chan KL Francis
2006.296 New Parallel Perfusion Imaging by Cardiac Magnetic Resonance in Patients with Suspected Coronary Artery Disease CHAN Kin Yin Anna
2007.120 A Randomized, Double-Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen Dr. Chan Kin Wing
2007.163 The Use of Pulsed Radiofrequency Treatment in Spinal Nerve Root Pain Dr. Chan Kin Cheong Simon
2006.119 Identification of Viral Peptide Candidates for the Development of Second Generation Cervical Cancer Vaccines Tailored for Chinese Women CHAN Key Sheung Paul
2006.468 Hope-Inspiring (Fostering) Nursing Intervention for Improving the Quality of Life in Chinese Heart Failure Patients in Hong Kong CHAN Keung Sum

Page 262 of 265.